Drug
Alis
Alis: highest development phase Phase 3, developed by Insmed. 2 trial records tracked on RxWires.
- Highest phase
- Phase 3
- Developer
- Insmed
Trials
| Drug | Phase | Indication |
|---|---|---|
| ALIS NCT04677569 | Phase 3 | Mycobacterium Infections, Nontuberculous |
| ALIS NCT04677543 | Phase 3 | Mycobacterium Infections, Nontuberculous |
Latest
No recent events.
Follow Alis on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.